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Objectives/Hypothesis: To study the utilization of balloon catheter dilation (BCD) compared to traditional endoscopic
sinus surgery (ESS)
Study Design: Cross-sectional analysis
Methods: Cases identified by Current Procedural Terminology codes as BCD (2,717) or traditional ESS (31,059) were
extracted from the State Ambulatory Surgery Databases 2011 for California, Florida, Maryland, and New York. Patient demo-
graphics, surgical center and surgeon volume, mean charge, and operating room (OR) time were compared.
Results: There were 33,776 patients who underwent sinus surgery in the included states in 2011. Of these, 4.6% of maxil-
lary, 5.6% of sphenoid, and 13.9% of frontal procedures were performed using BCD. Adjusted analyses found increased use of
BCD in patients with chronic diseases(P<.001). Patients who had limited sinus surgery were less likely to have BCD compared
to patients who had all four sinuses instrumented (P<.001). Surgeons who performed a medium (odds ratio 1.38 [1.14–1.65])
or high (odds ratio 1.71 [1.42–2.07]) volume of ESSs were more likely to use BCD compared to those who performed a low vol-
ume (P<.001). However, among surgeons who utilized BCD, there was a minimal relationship between the percentage of sur-
geries performed with BCD and the surgeon’s total number of cases (R25 0.055). Compared to traditional ESS, the median
charges for maxillary/ethmoid procedures (mini-ESS) involving BCD were approximately $4,500 (P<.001) and maxillary/eth-
moid/sphenoid/frontal procedures (pan-ESS) were approximately $2,950 (P5.003) greater, whereas the median OR time involv-
ing BCD was 8 minutes less for mini-ESS procedures(P5.01) but not statistically different for pan-ESS procedures (P5.58).
Conclusions: In the study sample, balloon technology was used in 8.0% of ESS cases in 2011. Procedures using BCD
were on average more expensive compared to traditional ESS procedures, with minimal decrease in OR time.
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INTRODUCTION
The current literature suggests that balloon cathe-
ter dilation (BCD) can safely dilate the frontal, sphenoid
and maxillary sinuses with ostial patency in a large
number of cases for up to two years. However, limita-
tions to the current evidence preclude conclusive recom-
mendations on how to apply BCD in the treatment of
rhinosinusitis.1,2 There have been few rigorous trials
comparing its risks and benefits to traditional endo-
scopic sinus surgery (ESS), and as a result of this lim-
ited evidence the 2012 European Position Paper on
Rhinosinusitis and Nasal Polyps guidelines conclude,
“Overall, the place of these systems in the sinus sur-
geon’s armamentarium remains unclear (Evidence Level
IV).”1–4 BCD technology appears to have widespread
adoption by surgeons across the United States,3 but the
prevalence of use has not previously been described.
The application of balloon catheters for sinus dila-
tion was initially described by Lanza5 in 1993, and bal-
loon catheter technology was approved by the US Food
and Drug Administration (FDA) in April 2005. However,
BCD was not assigned specific Current Procedural Ter-
minology (CPT) codes until January 1, 2011. Previously,
BCD was assigned CPT code 31299 (unlisted procedure,
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accessory sinus),6 limiting the ability to specifically
study BCD adoption on a national level.
The objectives of this study were to: 1) quantify
how often BCD versus traditional ESS is being per-
formed, 2) describe the demographics of the patient pop-
ulation undergoing BCD compared to traditional ESS, 3)
determine how the utilization of the technology differs
based on surgical volume, and 4) calculate the orbital
complications, mean charges, and mean operating room
(OR) times for the two surgical techniques.
MATERIALS AND METHODS
Data Source and Subjects
We used the State Ambulatory Surgery Database (SASD) of
California, Florida, Maryland, and New York for 2011, the first
year that CPT codes for BCD were available. SASD is a product of
the Healthcare Cost and Utilization Project (HCUP), conducted
by the federal Agency for Healthcare Research and Quality.7
These states were selected to gain a wide geographic distribution.
The databases capture all hospital-based ambulatory surgery
encounters, and additionally, freestanding ambulatory surgery
center encounters for Florida, California, and New York.7
Compilation of Analytic Dataset
We defined the study cohort from the state data files using
CPT codes. We extracted all patients with CPT codes for endo-
scopic sinus surgery (CPT 31233, 31235, 31254, 31255, 31256,
31267, 31276, 31287, 31288) and/or BCD (CPT 31295, 31296,
31297). We excluded patients <18 years of age, leaving 33,776
observations for demographic analysis.
To evaluate the effect of balloon use on total charges and
OR time, we further subset the dataset to exclude patients who
underwent procedures in addition to traditional ESS and/or
BCD other than inferior turbinate, septoplasty, polypectomy, or
concha bullosa procedures. These criteria left 19,592 observa-
tions for total charge analysis and 9,165 observations for OR
time analysis. Patients with OR times >500 minutes (n5 54)
were excluded from the OR time analysis, as these OR times
are unlikely for routine ESS.8 v2 analyses was performed to
determine whether coprocedures were distributed evenly
between the comparison groups.
Covariate Factors
We obtained patient demographic information including
age (categorized based on quintile), gender, race (white, black,
Hispanic, Asian/Pacific Islander, or other), number of chronic dis-
eases (0, 1–3, or 4), median income quartile of the patient’s Zip
code, and primary expected payer (private, Medicare, Medicaid,
or other). We obtained surgery center information including
urban versus rural location and hospital-based versus freestand-
ing ambulatory surgery center. We calculated the volume of pro-
cedures performed at each surgical site and determined terciles
for low (62 procedures annually), medium (63–138 procedures
annually), and high (139 procedures annually) volume surgery
centers. Only Maryland and Florida included data regarding sur-
geon identifiers, and so for these states we also calculated the vol-
ume of procedures performed by individual surgeons and
determined surgical volume terciles with equal number of sur-
geons: low (30 procedures annually), medium (31–60 proce-
dures annually) and high (60 procedures annually).
We also defined a variable for the count of types of sinus
procedures performed for each patient discharge.9 We defined
the number of sinuses procedures per case as the count of
sinuses operated upon (range, 1–4).9 The SASD dataset does
not distinguish between unilateral versus bilateral sinus proce-
dures.9 For this reason, paired procedures (e.g., bilateral maxil-
lary procedures) were only counted as a single-procedure type.
Outcome Measures
Despite being used by some otolaryngologists as a stand-
alone device, balloon instrumentation is most frequently used in
the operating room in conjunction with endoscopic sinus instru-
mentation.4,8 The CPT codes 31295–31297 are explicitly meant
for balloon-only sinus procedures, whereas the use of balloon
and endoscopic instrumentation for any given sinus must be
coded by the standard endoscopic codes. Therefore, the dataset
does not differentiate between cases where a single sinus is
opened with both balloon and traditional instrumentation, but
does allow for the differentiation of cases where some sinuses
were opened with BCD and others with ESS (for example, tradi-
tional maxillary antrostomy and ethmoidectomy combined with
BCD of the frontal sinuses). Therefore, for our analysis we com-
pared patients who underwent traditional ESS without BCD
(“traditional ESS”) versus patients who underwent combined
surgery using balloon catheter technology for at least one sinus,
with or without traditional ESS (“BCD”).
Outcomes of length of stay and death during admission
were obtained from the dataset. For identification of orbital
injury, patients were searched for CPT codes for canthotomy,
canthoplasty or orbital decompression and International Classi-
fication of Diseases, 9th Revision (ICD-9) codes for diplopia, ret-
robulbar hematoma, orbital hemorrhage, or blindness.10
To facilitate comparison of total charge and OR time, we
created variables for maxillary sinus only, mini-ESS (defined as
maxillary antrostomy either via endoscopic or balloon techni-
ques and ethmoidectomy), and for pan-ESS (defined as maxil-
lary, sphenoid, and frontal sinuplasty via endoscopic or balloon
techniques and ethmoidectomy). Other combinations of sinus
procedures that would fall between mini-ESS and pan-ESS
were included in an overall comparison. Of note, only the data-
set for New York contained information regarding OR time,
defined as the total time actually in the operating room exclu-
sive of preoperative (preparation) and postoperative (recovery)
time.
Maryland, New York, and Florida datasets included data
on total charges. The total charges do not include professional
fees and noncovered charges, and professional fees are removed
from the total charge during HCUP processing.7 A single total
charge value was reported by the surgical center without fur-
ther itemization.
Statistical Analysis
We used t tests for continuous variables and v2 or Fisher
exact tests for categorical variables to perform bivariate analy-
ses of patient factors; surgery center factors and volume; sur-
geon case volume; and outcomes between the groups of patients
who underwent traditional ESS or BCD procedures. We per-
formed multiple logistic regression to compare patient factors
and volume between patients undergoing ESS or BCD proce-
dures. Covariates were based on significance in prior studies or
statistical significance in the bivariate analyses. Variables with
significance at the P<0.1 level were included in the model per
convention.
The normality of the distribution for total charges and OR
time was tested by use of the Kolmogorov-Smirnov test statistic.
Because the total charge and OR time data (and the log of both)
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TABLE I.
Patient and Surgery Center Data for Endoscopic Versus Balloon/Combined Endoscopic Sinus Surgery.
Endoscopic Only Balloon/Combined
P Value
Total
No. % No. % No. %
Mean age, yr 48.906 15.73 48.27615.40 t test
.044
48.85615.71
Age quintiles, yr
<34 6,041 19.45% 537 19.76% v2 .19 6,578 19.48%
34–44 6,301 20.29% 560 20.61% 6,861 20.31%
45–52 5,862 18.87% 539 19.84% 6,401 18.95%
53–62 6,334 20.39% 563 20.72% 6,897 20.42%
>62 6,521 21.99% 518 19.07% 7,039 20.84%
Sex
Female 15,301 49.69% 1,424 52.74% v2 .002 16,725 49.93%
Male 15,493 50.31% 1,276 47.26% 16,769 50.07%
Race
White 21,852 74.16% 2,098 79.95% v2 <.001 23,950 74.63%
Black 1,877 6.37% 119 4.54% 1,996 6.22%
Hispanic 3,105 10.54% 260 9.91% 3,365 10.49%
Asian/Pacific Islander 1,154 3.92% 56 2.13% 1,210 3.77%
Other 1,478 5.02% 91 3.47% 1,569 4.89%
No. of chronic diseases
0 1109 3.57% 44 1.62% v2 <.001 1,153 3.41%
1–3 25,325 81.54% 2,186 80.46% 27,511 81.45%
>4 4,625 14.89% 487 17.92% 5,112 15.14%
Payer
Private 21,733 69.97% 1,968 72.43% v2 <.001 23,701 70.17%
Medicare 5,764 18.56% 482 17.74% 6,246 18.49%
Medicaid 1,895 6.10% 178 6.55% 2,073 6.14%
Other 1,667 5.37% 89 3.28% 1,756 5.20%
Median household state
income quartile for patient Zip code
1 5,149 16.85% 414 15.49% v2 <.001 5,563 16.74%
2 7,247 23.72% 698 26.11% 7,945 23.91%
3 8,093 26.49% 776 29.03% 8,869 26.70%
4 10,061 32.93% 785 29.37% 10,846 32.65%
Urban/rural
Large metropolitan (>1 million) 22,245 71.81% 1,767 65.13% v2 <.001 24,012 71.27%
Small metropolitan (<1 million) 6,956 22.45% 739 27.24% 7,695 22.84%
Micropolitan/rural 1,778 5.74% 207 7.63% 1,985 5.89%
Ambulatory surgery center*
Hospital based 25,497 82.09% 2,250 82.81% v2 .35 27,747 82.15%
Freestanding 5,562 17.91% 467 17.19% 6,029 17.85%
Hospital volume
Low 10,320 33.23% 904 33.27% v2 <.001 11,224 33.23%
Medium 10,425 33.57% 1,082 39.82% 11,507 34.07%
High 10,314 33.21% 731 26.90% 11,045 32.70%
Surgeon volume†
Low 4,081 34.17% 241 27.29% v2 <.001 4,322 33.69%
Medium 3,718 31.13% 314 35.67% 4,033 31.44%
High 4,145 34.70% 327 37.035 4,472 34.86%
No. of operated sinus types
1 7,187 23.14% 451 16.60% v2 <.001 7,638 22.61%
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were not normally distributed, we used the Wilcoxon rank sum
nonparametric test for bivariate analyses assessing cost and OR
time between the group of patients who underwent BCD or tra-
ditional ESS during maxillary-only, mini-ESS, pan-ESS, or any
sinus procedure. A multivariate generalized linear model was
created using a gamma distribution and logarithmic transfor-
mation for the dependent variable.11,12 We also performed a
matched cohort analysis of patients who underwent a maxillary
sinus-only procedure to compare results to the generalized lin-
ear model. One hundred fifty-five of the patients who under-
went endoscopic maxillary antrostomy only were randomly
sampled from the available 2,085 patients and matched to the
155 patients in the maxillary balloon dilation-only group using
SAS PROC SURVEYSELECT (SAS Institute Inc., Cary, NC).
The cohort was analyzed by an adjusted random effects Poisson
regression in Stata (StataCorp LP, College Station, TX) using
xtpoisson.
We performed all other data management and analyses
with SAS (SAS Institute Inc.). Statistical significance was deter-
mined at a two-tailed level of P<.05. The Northwestern Univer-
sity Institutional Review Board deemed this study of publicly
available de-identified information exempt from human subjects
reviews.
RESULTS
In 2011 in California, Florida, Maryland, and New
York, 33,776 balloon or endoscopic sinus surgeries were
performed (Table I) at 738 facilities. Within the subset of
patients from Florida and Maryland who had unique
surgeon identifier codes, 581 surgeons performed 12,827
sinus surgeries.
Table II contains the patient, surgical center, and
surgeon demographic data among traditional ESS versus
combined procedure groups. Adjusted analysis found
that black and Asian patients and patients who identi-
fied as “other” were less likely than white patients to
have a balloon procedure (P<.001) (Table III). Men had
lower odds of having BCD compared to women
(P<.001). Patients with chronic diseases were more
likely to undergo BCD compared to patients with none
(P<.001). Patients who were self-pay or had free care
were less likely to have BCD compared to patients with
private insurance (P<.001). Patients in New York were
more likely to have a balloon procedure compared to
patients in California (P<.001). Patients who had a lim-
ited sinus surgery were less likely to have BCD com-
pared to patients who had all four sinuses instrumented
(P<.001). Surgical centers that performed a high volume
of ESSs were less likely to utilize BCD compared to
those who performed a low volume (P<.001).
Individual surgeon identifier variables were only
available for the states of Florida and Maryland. For
these two states, a variable regarding surgeon volume
was added to the model, which found that surgeons who
performed a medium or high volume of ESS had greater
odds of utilizing BCD compared to those who performed a
low volume of sinus surgery (medium odds ratio (OR) 1.38
[1.14-1.65], high OR 1.71 [1.42-2.07], P<.001]. Among
surgeons who utilized BCD, there was no correlation
between the percentage of surgeries performed with BCD
and the total number of surgeries (b520.088, t5218.08,
P<.001, R25 0.055). Similarly, among surgeons who per-
formed frontal sinus BCD, there was no correlation
between percentage of frontal sinus procedures performed
with BCD and total number of frontal procedures per-
formed (b520.059, t521.33, P5.18, R25 0.0027).
There was no difference in length of stay for
patients undergoing traditional versus combined proce-
dures (v2 P5.32). No patient in the sample died during
their ambulatory surgery admission. There was no dif-
ference in the rates of orbital surgery for possible diag-
noses of orbital complications between patients
undergoing traditional versus combined procedures
(endoscopic 0.05%, combined 0.05%, Fisher P 5 1.00). In
the comparison group for cost and operating room time,
87.8% of patients had a coprocedure. There was no sig-
nificant difference between the endoscopic and balloon
patient groups in terms of rates of coprocedures (maxil-
lary sinus only P5.11, mini-ESS P5.18, pan-ESS
P5.66, and all ESS procedures P5.82).
The Wilcoxon rank sum test found that the
median charges for maxillary sinus-only, mini-ESS, and
pan-ESS procedures involving BCD were $1,864,
$4,504, and $2,953.50 greater, respectively, compared to
traditional ESS alone (maxillary sinus only P<.001,
mini-ESS P<.001, Pan-ESS P5.003) (Table IV). The
median OR time was 8 minutes less for mini-ESS
TABLE I.
(Continued)
Endoscopic Only Balloon/Combined
P Value
Total
No. % No. % No. %
2 10,778 34.70% 598 22.01% 11,376 33.68%
3 7,351 23.67% 1,051 38.68% 8,402 24.88%
4 5,743 18.49% 617 22.71% 6,360 18.83%
State
California 9,375 30.18% 656 24.14 % v2 <.001 10,031 29.70%
Maryland 2,242 7.22% 122 4.49% 2,364 7.00%
New York 9,723 31.30% 1,178 43.36% 10,901 32.27%
Florida 9,719 31.29% 761 28.01% 10,480 31.03%
*Data from Maryland only include hospital-based surgery centers.
†Surgeon volume data are only available for Maryland and Florida.
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procedures using BCD but not statistically different for
maxillary-only or pan-ESS procedures (mini-ESS P5.01,
maxillary only P5 1.0, pan-ESS P5.58) (Table V). Con-
trolling for gender, age, race, number of chronic diseases,
primary payer, median income of patient’s Zip code,
urban versus rural location of surgical center, state (in
the model for charge but not OR time), surgical center
volume, and freestanding versus hospital surgery center,
BCD during maxillary sinus-only surgery resulted in a
37.3% percent increase in the total charge (P<.001), and
no significant difference in OR time compared to a proce-
dure utilizing only traditional ESS technology (P5.84).
The generalized linear model found that BCD during
mini-ESS and pan-ESS resulted in a 31.4% and 18.5%
increase, respectively, in the total charge (P<.001,
P<.001), and a 14.7% decrease in OR time (P5.002) for
mini-ESS OR time but no statistically significant differ-
ence in pan-ESS OR time (P5.46).
The matched cohort Poisson regression analysis of
patients who underwent only maxillary antrostomy
yielded an incident rate ratio of 1.43 (1.26-1.63,
P<.001), which is within the confidence interval of the
generalized linear model (GLM) results (Table IV).
Because the Poisson regression of the matched cohort
uses data from only a sample of the patients who under-
went an endoscopic maxillary antrostomy, GLM was
used for the remainder of the analysis.
DISCUSSION
This cross-sectional study examined data from four
states, California, Florida, Maryland, and New York, for
patients 18 years old who underwent endoscopic or bal-
loon sinus surgery in 2011, the first year CPT codes
were available for BCD. Overall, 33,776 patients under-
went paranasal sinus surgery in the included states, and
4.6% of maxillary, 5.6% of sphenoid, and 13.9% of frontal
procedures were performed utilizing BCD. We found
racial and provider-dependent differences in the use of
BCD. Surgeons who performed a medium or high vol-
ume of ESS were more likely to utilize BCD compared to
those who performed a low volume. However, among
surgeons who utilized BCD, there was a minimal rela-
tionship between the percentage of surgeries performed
with BCD and the surgeon’s total number of cases. Pro-
cedures using balloon technology were on average more
expensive compared to procedures that utilized only
endoscopic techniques with minimal decrease in operat-
ing room time.
Proponents of BCD emphasize that BCD is less
invasive in terms of less distortion of the original anat-
omy and less mucosal disruption, thereby minimizing
potential for synechiae formation and ostial stenosis.13,14
Case series, nonrandomized retrospective comparative
trials, and one small randomized clinical trial have
reported sinus patency rates and durability of clinically
significant symptomatic improvement for up to 2 years
after BCD for both systems.8,15–20 BCD may be advanta-
geous in the setting of anatomic variants such as
obstructing type III or IV frontal cells that are less
accessible to current endoscopic instrumentation,4 or in
the management of immunocompromised and critically
ill patients with acute rhinosinusitis.21 BCD also may be
used in the office setting, with minimal or no local anes-
thesia requirements.22,23
A potential drawback of BCD is that the instru-
mentation is not reusable between patients, and the
cost of the disposable instrumentation may increase the
total cost of the procedure, as we suggest in this
report.3,14 Proponents of BCD have argued that the
cost of the technology may be offset by reduced operat-
ing room time, decreasing charges from the operating
facility and the anesthesia team, but this analysis does
not support that idea.14 Another limitation of BCD is
that complex frontal recess pneumatization patterns
and significant osteoneogenesis may make BCD chal-
lenging or impossible.24 Therefore, a surgeon attempt-
ing BCD should be able to perform endoscopic
procedures if BCD is unable to achieve the desired
results.1,4,24,25 Additionally, patients with extensive
mucosal disease, such as polyps, are generally not can-
didates for the current generation of catheters, because
the goal of treatment in such cases is resection of
edematous, inflamed mucosa.1,4,26 Moreover, current
TABLE II.
Total Number of Sinus Procedures Performed During Endoscopic-Only, Balloon-Only, and Combined ESS in Hospital-Based or Freestand-
ing Ambulatory Surgery Centers in California, Florida, Maryland, and New York in 2011.
No. of Procedures
Maxillary
Ethmoid
Sphenoid Frontal
Type of ESS Traditional Balloon Traditional Traditional Balloon Traditional Balloon
No. of Patients
(% of Patients)
Endoscopic technology only 26,532 — 25,242 10,063 — 11,931 — 31,059 (91.96%)
Balloon technology only — 580 — — 217 — 398 746 (2.21%)
Combined* 1,112 761 1805 467 403 177 1,550 1,971 (5.84%)
Total 27,644 1,341 27,047 10,530 620 12,108 1,948 33,776
% of procedures 95.37% 4.63% NA 94.44% 5.56% 86.14% 13.86%
Overall total 28,985 NA 11,150 14,056
*Combined cases defined as those in which some sinuses are operated on using endoscopic technology, whereas other sinuses undergo balloon cathe-
ter dilation (e.g., endoscopic maxillary antrostomy and ethmoidectomy with frontal sinus balloon dilation).
ESS5 endoscopic sinus surgery.
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literature provides little guidance regarding what risk
factors may make patients better candidates for BCD
versus traditional ESS.27
Because our study is limited to data from only four
states, it is difficult to know how generalizable the
results are. However, the demographic profile of patients
in our sample undergoing endoscopic only or combined
procedures is similar to the constructed demographic
profile of patients undergoing sinus surgery for chronic
rhinosinusitis created by Martin et al.28 Our study had
a similar percentage of females, racial/ethnic groups,
and private insurance.28 Moreover, Martin et al. found
that 93.5% of sinus surgery is performed on an outpa-
tient basis, so although our study sample includes only
sinus surgery performed at ambulatory surgery centers,
it most likely represents the majority of sinus surgery
performed in an operating room in these states during
2011.28
We found that a greater percentage of patients who
underwent combined procedures had frontal sinusotomy:
38.4% of cases involving ESS only included frontal sinus
instrumentation, whereas 63.6% of combined cases
involved frontal sinus instrumentation. Although our per-
centage of procedures utilizing BCD only is similar to that
of Levine et al., a larger percentage of patients in our sam-
ple underwent frontal sinusotomy, and the average operat-
ing room time was longer.8 In Levine et al.’s registry, the
average surgery time was 73.0 minutes (median, 60
minutes; range, 6–230 minutes).8 Our results showed a
mean time for BCD cases of 104.9 minutes (median, 93.5
minutes; interquartile range, 69–129 minutes). The dis-
crepancy could be partially explained by the fact that a
higher percentage of patients in our data from 2011 had
instrumentation of their frontal sinus compared to those in
the registry, which included data from 2005 to 2007. Pyn-
nonen and Davis found that the population-adjusted rates
of sinus surgery increased during the 10-year period from
2000 to 2009 in the state of Florida, and the number of pro-
cedures per case also increased, with rates of frontal sinus
procedures more than doubling, and rates of cases for
which all four sinuses were treated tripling during the
same time period.9 It is not possible to determine the
extent to which BCD contributed to the observed
increases.9 Further studies are necessary to determine if
balloon technology influences rates of surgery, especially of
the frontal sinus and procedures involving all four sinuses.
In contrast to Friedman et al., we found that at
ambulatory surgery centers, the total charge associated
with BCD procedures was greater than that of tradi-
tional ESS procedures. Friedman et al. evaluated cost
for 70 patients with chronic rhinosinusitis who under-
went BCD or traditional ESS.16 They found that equip-
ment charges were higher for BCD, and a significantly
decreased cost of revision procedures using BCD contrib-
uted to difference seen in overall cost.16 We are unable
to determine if procedures in our dataset were primary
or revision surgeries. Our findings are difficult to fur-
ther compare to Friedman et al.’s because their article
does not indicate the extent of surgery performed.16
Although the non-normality of our total charge and
OR time data made statistical analysis difficult, the
TABLE III.
Logistic Regression for Odds of Combined Procedure
Compared to Endoscopic Procedure.
Odds
Ratio
95%
Confidence
Interval
Analysis
of
Effects
P Value
Gender
Female — — <.001
Male 0.87 0.80-0.94
Age
<34 years — — .29
34–44 years 0.98 0.86-1.12
45–52 years 1.00 0.88-1.14
53–62 years 0.94 0.82-1.07
63 years 0.84 0.71-1.00
Race
White — — <.001
Black 0.69 0.56-0.84
Hispanic 0.98 0.85-1.13
Asian 0.56 0.42-0.74
Other 0.55 0.44-0.69
No. of chronic diseases
0 — — <.001
1–3 1.71 1.24-2.36
>4 2.00 1.43-2.80
Primary payer
Private — — <.001
Medicare 1.00 0.86-1.17
Medicaid 0.96 0.80-1.14
Self/free care 0.58 0.46-0.73
Median household state
income quartile for patient Zip code
1 — — .005
2 1.12 0.98-1.28
3 1.18 1.03-1.35
4 0.99 0.86-1.13
Urban/rural
Large metropolitan (>1 million) — — .058
Small metropolitan (<1 million) 1.13 1.02-1.25
Micropolitan/rural 1.11 0.93-1.32
State
California — — <.001
Florida 1.05 0.92-1.17
Maryland 0.88 0.71-1.08
New York 1.84 1.65-2.06
Volume
Low — — <.001
Medium 1.10 1.00–1.21
High 0.71 0.64-0.80
No. of sinus types
1 0.58 0.51-0.66 <.001
2 0.50 0.45-0.57
3 1.30 1.16-1.45
4 — —
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issue of nonparametric data is common in econometric
analysis and has been studied extensively.11 We followed
standard statistical practice by performing nonparamet-
ric comparison of means testing and analyzing our data
with models that did not necessitate normality in their
assumptions.11,12
Our study faces many of the challenges associated
with analyzing administrative data. There is a disparity
in the collected variables across states. There are limita-
tions with using CPT codes to identify cases, as proce-
dures that utilize both balloon and endoscopic
technology to open a single sinus should be reported
using endoscopic codes, and these hybrid procedures
would be missed by our analysis. This may lead to an
underestimation of the true extent of the utilization of
balloon technology and may miscategorize some proce-
dures that used balloon technology as only ESS, which
would be expected to lead to an underestimation of the
true difference in charges between procedure types. The
inability to distinguish unilateral from bilateral proce-
dures may be perceived as a limitation, and although we
recognize this perspective, we believe that the salient
information is the extent of surgical dissection per-
formed.9 Due to the nature of the dataset, it is not possi-
ble to know the indications for surgery. This is especially
important for the identification of orbital complications,
which we searched for using both the ICD-9 code for
diagnosis and CPT code for procedure.10 It is not possible
to know if these diagnoses were preexisting or a compli-
cation of the sinus procedure. However, the rate of
orbital complication identified by this method is in keep-
ing with prior estimates of the rate of orbital complica-
tions during sinus surgery.10
Finally, our data do not capture in-office BCD, as our
dataset only includes procedures in ambulatory surgery
centers. Prior studies have shown that BCD technology
can be safely used in the office setting under local anesthe-
sia for patients with or without a prior history of ESS, with
high patient satisfaction and sustained symptom improve-
ment.22,23,29–34 In-office BCD may prove to be cost-effective
and time-efficient,35 but further studies are necessary to
compare the costs of in-office BCD to resource utilization of
surgical management in the operating room.
CONCLUSION
Balloon technology was used in 8.0% of ESSs in
ambulatory surgery centers in the sampled states in
TABLE IV.
Comparison of Median Charge Between Endoscopic and Balloon/Combined Maxillary Sinus Only, Mini-ESS, Pan-ESS, and All ESS
Procedures.
Procedure
Total Charge*
Wilcoxon Rank
Sum P Value
Generalized Linear ModelEndoscopic Balloon/Combined
No. Median
Interquartile
Range No. Median
Interquartile
Range
Estimate of
Coefficient P Value
Maxillary
sinus only
2,085 $9,827.00 $4961.00–
$16,000.00
155 $11,691.00 $7,928.00–
$16,768.00
<.001 0.37 <.001
Mini-ESS 5,668 $12,231.00 $7,998.50–
$19,516.00
151 $16,735.00 $9,670.00–
$20,724.00
<.001 0.31 <.001
Pan-ESS 3,560 $17,398.50 $11,116.50–
$29,291.50
409 $20,352.00 $11,369.00–
$34,104.00
.003 0.19 <.001
All ESS 17,887 $13,680.00 $8,367.00–
$22,778.00
1,705 $16,615.00 $10,519.00–
$26,304.00
<.001 0.22 <.001
*Total charge data in dollars were available for Florida, Maryland, and New York.
ESS5 endoscopic sinus surgery; Mini-ESS5maxillary/ethmoid sinus surgery; Pan-ESS5maxillary/ethmoid/sphenoid/frontal sinus surgery.
TABLE V.
Comparison of Median OR Time Between Endoscopic and Balloon/Combined Maxillary Sinus Only, Mini-ESS, Pan-ESS, and All ESS
Procedures.
Procedure
OR Time, min*
Wilcoxon
Rank
Sum P Value
Generalized Linear ModelEndoscopic Balloon/Combined
No. Median
Interquartile
Range No. Median
Interquartile
Range
Estimate of
Coefficient
P
Value
Maxillary sinus only 788 76 55–110 79 75 55–107 1.0 20.012 .84
Mini-ESS 2,807 90 62–120 125 82 60–101 .01 20.15 .002
Pan-ESS 1,681 111 74–152 222 117 82–146 .58 0.036 .46
All ESS 8,185 92 64–130 980 93.5 60–69 .36 20.017 .35
*OR time data in minutes were available for New York.
ESS5 endoscopic sinus surgery; Mini-ESS5maxillary/ethmoid sinus surgery; OR5operating room; Pan-ESS5 xillary/ethmoid/sphenoid/frontal sinus
surgery.
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2011. Surgeons who performed a medium or high volume
of sinus surgeries were more likely to utilize balloon
technology compared to surgeons who performed a low
volume of procedures. The association of procedural pat-
terns with specific surgeons in sinusitis care highlights
the importance of future investigations to examine train-
ing, technological, and reimbursement factors that may
influence surgeon’s clinical decision making. Procedures
using balloon technology in the operating room were on
average more expensive compared to procedures that
utilized only endoscopic techniques, with minimal
decrease in operating room time. This study does not
capture in-office BCD, which may prove to be cost-
effective and time-efficient.
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